Target intelligence / Profile preview

MRPS30 divergent transcript (MRPS30-DT)

Target
MRPS30-DT
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

MRPS30 divergent transcript (MRPS30-DT) is a long non-coding RNA (lncRNA) gene located on chromosome 5 (5p12), also known by the aliases BRCAT54, BRCAT107, and LINC02224. It does not code for a protein and is primarily identified through its altered expression in breast cancer. The detailed molecular function and biological roles of MRPS30-DT remain largely uncharacterized, but it is associated with certain cancers, specifically breast cancer, where it may play a role in oncogenesis or cancer progression[1][2][3][6]. There are currently no known drugs that directly target MRPS30-DT, and it is not considered a canonical therapeutic target or receptor.

Other names
BRCAT54BRCAT107LINC02224breast cancer-associated transcript 54breast cancer-associated transcript 107long intergenic non-protein coding RNA 2224
02

Biological functions

Other (potential involvement in transcriptional regulation, but specific functions are not well defined)
03

Disease associations

Cancer (notably breast cancer)

Beyond the preview

Go deeper on MRPS30 divergent transcript (MRPS30-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MRPS30 divergent transcript (MRPS30-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call